Awards for “ACTELION PHARMACEUTICALS US, INC”
25 awards on this page · sorted by amount · page 5
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| 15B50926F00000097 | ACTELION PHARMACEUTICALS US, INC. | Department of Justice | $77.05K | 2026-06-01 | 2026-06-30 | 325412 | FY26-PHARMACY ACTELION (UPTRAVI/OPSUMIT) JUNE |
| 36C26318N0242 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $76.83K | 2018-01-12 | 2019-12-19 | 325412 | EMERGENCY DRUG ORDER - UPTRAVI |
| 36C26321F0016 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $76.78K | 2020-10-15 | 2021-09-30 | 325412 | OPSUMIT 10MG TABLET |
| VA26012F0026 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $76.65K | 2011-10-01 | 2012-09-30 | 325412 | ZEISS SERVICE AGREEMENT FOR FY12 |
| 36C26018N0505 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $75.69K | 2018-03-01 | 2018-10-10 | 325412 | SELEXIPAG UPTRAVI |
| 36C24718K0041 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $75.39K | 2017-10-16 | 2018-09-30 | 325412 | EXPRESS REPORT: FOR PHARMACY ORDERING OFFICER ORDERS FOR TRACLEER FOR FY18 |
| VA24112F0126 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $75K | 2011-10-01 | 2012-09-28 | 325412 | MEDS FOR PHARMACY |
| 15B50525F00000108 | ACTELION PHARMACEUTICALS US, INC. | Department of Justice | $72.52K | 2025-02-01 | 2025-02-28 | 325412 | OPSUMIT 10MG-QTY 6 @ 6,270.03 UPTRAVI 1600MCG QTY 1 @ 22,743.10 ADEMPAS 1MG, QTY 1 @ 12,153.05 FEBRUARY 2025 |
| 15B50525F00000068 | ACTELION PHARMACEUTICALS US, INC. | Department of Justice | $72.52K | 2025-01-31 | 2025-01-31 | 325412 | OPSUMIT 10MG-QTY 6 @ 6,270.03 UPTRAVI 1600MCG QTY 1 @ 22,743.10 ADEMPAS 1MG, QTY 1 @ 12,153.05 JANUARY 2025 |
| 15B50525F00000062 | ACTELION PHARMACEUTICALS US, INC. | Department of Justice | $72.23K | 2024-12-01 | 2024-12-31 | 325412 | OPSUMIT 10MG-QTY 6 @ 6,270 UPTRAVI 1600MCG QTY 1 @ 22,743.10 ADEMPAS 1MG, QTY 1 @ 11,863.58 DECEMBER 2024 |
| 15B50525F00000032 | ACTELION PHARMACEUTICALS US, INC. | Department of Justice | $72.23K | 2024-11-01 | 2024-11-30 | 325412 | APPROVED CURASCRIPT REQUEST NOV FY25 OPSUMIT 10MG-QTY 6 @ 6,270 UPTRAVI 1600MCG QTY 1 @ 22,743.10 ADEMPAS 1MG, QTY 1 @ 11,863.58 |
| 15B50525F00000014 | ACTELION PHARMACEUTICALS US, INC. | Department of Justice | $72.23K | 2024-10-01 | 2024-10-31 | 325412 | OPSUMIT 10MG-QTY 6 @ 6,270 UPTRAVI 1600MCG QTY 1 @ 22,743.10 ADEMPAS 1MG, QTY 1 @ 11,863.58 |
| 36C26221F0497 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $71.88K | 2021-09-09 | 2022-01-31 | 325412 | HYPERTENSION MEDICATION |
| 36C26025F0107 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $70.63K | 2025-02-09 | 2025-08-07 | 325412 | SELEXIPAG (UPTRAVI) TABS, PHARMACEUTICALS. |
| 36C26223F0196 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $70.17K | 2023-02-04 | 2024-02-05 | 325412 | SPECIALTY MEDICATIONS |
| 15B50523F00000136 | ACTELION PHARMACEUTICALS US, INC. | Department of Justice | $69.46K | 2023-07-01 | 2023-09-15 | 325412 | CURASCRIPT, UPTRAVI, FY23 |
| 36C24718K0147 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $69.02K | 2016-10-01 | 2017-09-30 | 325412 | EXPRESS REPORT: FOR PHARMACY ORDERING OFFICER ORDERS FOR PHARMACEUTICALS FOR FY17 |
| VA26314F0010 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $68.21K | 2013-10-03 | 2015-10-21 | 325412 | TRACLEER; MEDICATION |
| 36C26026F0024 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $65.5K | 2025-10-01 | 2026-09-30 | 325412 | PHARM - VELETRI |
| VA26118F2911 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $65.09K | 2017-10-01 | 2020-05-14 | 325412 | UPTRAVI |
| 36C26021F0016 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $65.04K | 2020-10-01 | 2021-09-30 | 325412 | FUNDING FOR ACCREDO (VELETRI) |
| 36C26119F0009 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $65.01K | 2018-10-01 | 2021-01-14 | 325412 | UPTRAVI |
| 36C26023F0007 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $65K | 2022-10-01 | 2023-09-30 | 325412 | VELETRI INJECTABLE |
| 36C26218N4499 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $64.98K | 2018-04-01 | 2018-09-30 | 325412 | SELEXIPAG (UPTRAVI) POP: 4/1/2018 TO 9/30/2018 |
| VA26017F0786 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $64.51K | 2017-02-17 | 2018-02-16 | 325412 | BOSENTAN |